Dow Up0.15% Nasdaq Up0.21%

Oxygen Biotherapeutics, Inc. (OXBT)

-NasdaqCM
4.02 Down 0.08(1.95%) 3:59PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
OXBTNVSPFERHHBYIndustry
Market Cap:112.99M229.81B192.45B253.89B202.43M
Employees:14135,00077,70085,08058.00
Qtrly Rev Growth (yoy):N/A0.03-0.020.010.18
Revenue (ttm): 95.41K59.33B50.33B52.18B13.14M
Gross Margin (ttm):N/A0.660.820.750.53
EBITDA (ttm):-17.29M16.66B21.83B20.19B-12.62M
Operating Margin (ttm): -182.760.200.320.34-1.57
Net Income (ttm):-23.18M9.22B10.37B11.52BN/A
EPS (ttm):-3.673.923.221.80-0.35
P/E (ttm):N/A24.169.4220.7932.17
PEG (5 yr expected):N/A2.204.222.640.05
P/S (ttm):1,207.803.863.794.8816.36
 
NVS = Novartis AG
PFE = Pfizer Inc.
RHHBY = Roche Holding AG
Industry = Biotechnology

Biotechnology Companies Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN140.710.01106.88B22.84
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB327.580.0077.36B40.74
Genzyme CorporationPrivate - View Profile
Merck Serono S.A.Private - View Profile
Gilead Sciences Inc.GILD103.84-0.01156.97B38.46
MedImmune, L.L.C.Private - View Profile
Life Technologies CorporationPrivate - View Profile
Teva Pharmaceutical Industries LimitedTEVA52.370.0044.71B32.35
Sandoz International GmbHPrivate - View Profile
 
View Biotechnology Industry Center

Generic Drugmakers Ranked by Sales 
CompanySymbolPriceChangeMarket CapP/E
Actavis plcACT237.09-0.0162.65BN/A
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL48.000.0017.95B29.98
Pfizer Inc.PFE30.350.01192.45B9.42
Johnson & JohnsonJNJ106.190.00299.49B20.31
GlaxoSmithKline plcGSK47.10-0.00113.13B13.39
SanofiSNY56.520.01148.32B29.01
Novartis AGNVS94.720.00229.81B24.16
Roche Holding AGRHHBY37.37-0.00253.89B20.79
AstraZeneca PLCAZN73.26-0.0192.53B44.92
 
View Biotechnology Industry Center

Drugmakers Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Abbott LaboratoriesABT43.380.0165.23B28.37
Bristol-Myers Squibb CompanyBMY50.88-0.0184.35B29.41
 
View Biotechnology Industry Center

 
News on Direct Competitors 

Currency in USD.